Isualization heart motion in fetal ultrasound examination. At this stage, about 6 to 8 weeks of pregnancy, the women are with their doctor before or dismissal, or one designated health care professional ICG-001 for appropriate prenatal care. 2.5.10. To attend the end of treatment, the end of treatment visit at the end of the induction phase of ovulation in women who con Oivent not included in the study, or with a pregnancy if women con Oivent be made. The end of treatment visit is as ttw During pregnancy such as m Be made possible. A brief overview with the addition of multiple assessments of acne and hirsutism performed with Sebumeter. Matters remain drug study carried their newspapers newspaper, and a lockable Assessment of the adverse events and concomitant medication is.
Baseline Ma took Be Chern all F, Including normal laboratory safety and Lebensqualit t surveys, a final collection of blood to the central laboratory to be repeated, will be picked up. For all women Danusertib with a positive pregnancy test, an obstetrical ultrasound is done to the Lebensf To determine conductivity of 6 to 8 weeks. For those women who have an ongoing pregnancy, precautions are taken to monitor the pregnancy outcomes at the end of the first quarter and also after delivery or termination of pregnancy. All pregnancies followed, the rate of abortions, to determine the rate of complications and to determine pregnancy. Participants will be informed about the study to inform employees of the outcome of pregnancy, and we get the release of application forms from their doctor in order to receive a copy of medical records.
Telephone contacts are started when the participants are not contacted by the study staff of 6 weeks after the original date of delivery. Shipping data records Tze will be asked to birth weight, gestational age, and to determine any perinatal complications of the mother or infant. This methodology has proven to be very effective for monitoring PPCOS I pregnancy outcome, and we will study more information about the course of the newborn child to become engaged Ngern. During this visit we will also obtain a separate consent to the S uglinge After birth followed to determine the results of neurological and behavioral development, such as below it Rtert. 05.02.11. Establish a pregnancy registry according to the guidelines recommended by the FDA, we intend to establish a pregnancy registry for this test to assess the outcome of pregnancy.
This Will overlapwith follows our existing protocol, but because the S Ugling after birth, we will create a separate log and we will make women stupid Oivent individually to participate in this extended protocol. We track the results of all randomized patients, the positive serum pregnancy test to screen in this study. We are the biochemical pregnancies, ectopic pregnancy, intrauterine pregnancy and all losses, both before and after 20 weeks Including Lich missed abortions, miscarriages, abortions to save to the F Lease status, and stillbirths. We are the F Ll of pregnancy and the birth mother and the F Status to morbidity T and mortality T in neonates and the presence of abnormal Q To determine status. The child will be at each site within 60 days after birth by dysmorphologist for m Possible considered malformations. Abnormal fetal u be classified